Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
Acta Clin Belg ; 76(6): 482-486, 2021 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-32285755

RESUMO

Objectives: Cytomegalovirus (CMV) infection is one of the most common complications in allogeneic hematopoietic stem cell transplant (allo-HSCT) recipients. The classic antiviral treatments have shown clinical efficacy but are often associated with drug resistance. Reconstitution of CMV-specific cellular immunity is essential in controlling CMV infection; therefore, adoptive transfer of CMV-specific T cells is a promising treatment option. We treated a patient with a multidrug resistant CMV infection after haploidentical HSCT with CMV-specific T cells.Methods: The T cells were derived from the HSCT donor who was CMV seropositive. We generated the T cells by a short-term Good Manufacturing Practice (GMP) grade protocol in which a leukapheresis product of the HSCT donor was stimulated with the immunodominant antigen pp65 and interferon-γ secreting cells were isolated. A total of 5 × 105 T cells were administered to the patient within 30 hours after leukapheresis.Results: The patient was closely monitored for reconstitution of antiviral T cell immunity and viral replication after adoptive T cell transfer. We observed an in vivo expansion of both CD4+ and CD8+ CMV-specific T cells associated with a significant decrease in viral burden and clinical improvement.Conclusion: This case report further supports the feasibility and effectiveness of adoptive donor T cell transfer for the treatment of drug resistant CMV infections after allo-HSCT.


Assuntos
Infecções por Citomegalovirus , Transplante de Células-Tronco Hematopoéticas , Citomegalovirus , Transplante de Células-Tronco Hematopoéticas/efeitos adversos , Humanos , Linfócitos T , Doadores de Tecidos
2.
J Biomed Mater Res A ; 103(8): 2720-30, 2015 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-25630382

RESUMO

The coating of fibrous polyester constructs with a layer of bioactive calcium phosphate (CP) is efficient to improve the potential use as bone tissue engineering scaffold. In this study, a fast procedure for the coating of electrospun poly(d,l-lactide) (PDLLA) fibers with a CP layer was optimized. The fiber surface was activated by immersion in demineralized water under ultrasonication. The resulting reactive groups served as nucleation points for CP precipitation, induced by alternate dipping of the samples in Ca(2+) and PO4 (3-) rich solutions. Variations in the conditions of the alternate dipping procedure, in particular the number of cycles, concentration and immersion time of both solutions, not only affected the degree of surface mineralization but also the type of deposited CP. For the current experimental conditions, in about 30 minutes either a slightly carbonated calcium deficient apatite (CDAp; Ca10-x-y (PO4 )6-x-y (HPO4 )y (CO3 )x (OH)2-x-y ) or a combination of apatite and dicalcium phosphate dihydrate (DCPD; CaHPO4 .2H2 O) was formed. The cell viability, adhesion, and proliferation of MC3T3-E1 cells on untreated samples were compared with samples coated with either an adequate amount of CDAp, an excess of CDAp or an excess of a combination of apatite and DCDP. After 7 days of culture the number of attached cells was significantly higher on all CP coated samples compared to the untreated PDLLA. In particular, the samples coated with an adequate amount of CDAp showed an exceedingly enhanced cell response with similar cell morphologies as the ones found on the positive control.


Assuntos
Fosfatos de Cálcio/química , Materiais Revestidos Biocompatíveis , Poliésteres/química , Células 3T3 , Animais , Camundongos , Espectroscopia de Infravermelho com Transformada de Fourier
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA